Biosimilars onkowissen
ASO Keyword Dashboard
Tracking 76 keywords for Biosimilars onkowissen in Google Play
Biosimilars onkowissen tracks 76 keywords (no keywords rank yet; 76 need traction). Key metrics: opportunity 70.5, difficulty 44.8.
The "onkowissen Biosimilars" app: innovative - interactive - educational
Tracked keywords
76
0 ranked • 76 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
70.5
Top keyword: entry
Avg difficulty
44.8
Lower scores indicate easier wins
Opportunity leaders
- 65.5
entry
Opportunity: 74.0 • Difficulty: 43.0 • Rank —
Competitors: 353
- 63.4
topic
Opportunity: 74.0 • Difficulty: 44.5 • Rank —
Competitors: 290
- 62.9
structure
Opportunity: 74.0 • Difficulty: 39.1 • Rank —
Competitors: 258
- 66.1
links
Opportunity: 74.0 • Difficulty: 49.6 • Rank —
Competitors: 506
- 65.9
presented
Opportunity: 74.0 • Difficulty: 40.9 • Rank —
Competitors: 401
Unranked opportunities
entry
Opportunity: 74.0 • Difficulty: 43.0 • Competitors: 353
topic
Opportunity: 74.0 • Difficulty: 44.5 • Competitors: 290
structure
Opportunity: 74.0 • Difficulty: 39.1 • Competitors: 258
links
Opportunity: 74.0 • Difficulty: 49.6 • Competitors: 506
presented
Opportunity: 74.0 • Difficulty: 40.9 • Competitors: 401
High competition keywords
new
Total apps: 367,596 • Major competitors: 23,543
Latest rank: — • Difficulty: 58.6
access
Total apps: 340,727 • Major competitors: 12,551
Latest rank: — • Difficulty: 58.5
find
Total apps: 308,601 • Major competitors: 17,763
Latest rank: — • Difficulty: 58.4
information
Total apps: 268,493 • Major competitors: 8,215
Latest rank: — • Difficulty: 54.8
simple
Total apps: 258,766 • Major competitors: 12,322
Latest rank: — • Difficulty: 55.1
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| new | 65 | 100 | 59 | 89 367,596 competing apps Median installs: 3,155 Avg rating: 4.0 | — | — | 23,543 major competitor apps |
| feed | 73 | 100 | 50 | 67 16,035 competing apps Median installs: 976 Avg rating: 4.0 | — | — | 954 major competitor apps |
| date | 68 | 100 | 53 | 79 93,615 competing apps Median installs: 797 Avg rating: 4.1 | — | — | 2,927 major competitor apps |
| information | 65 | 100 | 55 | 86 268,493 competing apps Median installs: 1,201 Avg rating: 4.0 | — | — | 8,215 major competitor apps |
| content | 67 | 100 | 56 | 82 131,764 competing apps Median installs: 2,364 Avg rating: 4.1 | — | — | 6,183 major competitor apps |
| educational | 70 | 100 | 47 | 76 61,129 competing apps Median installs: 1,115 Avg rating: 4.0 | — | — | 2,164 major competitor apps |
| modern | 69 | 100 | 49 | 78 79,034 competing apps Median installs: 1,184 Avg rating: 4.1 | — | — | 3,596 major competitor apps |
| find | 65 | 100 | 58 | 87 308,601 competing apps Median installs: 2,783 Avg rating: 4.1 | — | — | 17,763 major competitor apps |
| de | 73 | 100 | 43 | 68 17,879 competing apps Median installs: 1,575 Avg rating: 4.2 | — | — | 714 major competitor apps |
| dynamic | 70 | 100 | 49 | 74 45,621 competing apps Median installs: 1,851 Avg rating: 4.0 | — | — | 2,724 major competitor apps |
| access | 65 | 100 | 59 | 88 340,727 competing apps Median installs: 1,168 Avg rating: 4.0 | — | — | 12,551 major competitor apps |
| related | 70 | 100 | 48 | 76 57,733 competing apps Median installs: 1,803 Avg rating: 4.0 | — | — | 1,961 major competitor apps |
| comprehensive | 69 | 100 | 48 | 78 84,972 competing apps Median installs: 756 Avg rating: 4.1 | — | — | 2,156 major competitor apps |
| news | 69 | 100 | 50 | 78 81,532 competing apps Median installs: 1,146 Avg rating: 4.1 | — | — | 2,360 major competitor apps |
| simple | 66 | 100 | 55 | 86 258,766 competing apps Median installs: 2,077 Avg rating: 4.0 | — | — | 12,322 major competitor apps |
| contains | 69 | 100 | 48 | 77 66,707 competing apps Median installs: 5,001 Avg rating: 4.2 | — | — | 2,156 major competitor apps |
| current | 68 | 100 | 51 | 79 89,795 competing apps Median installs: 1,678 Avg rating: 4.0 | — | — | 3,657 major competitor apps |
| official | 68 | 100 | 53 | 80 111,343 competing apps Median installs: 901 Avg rating: 4.1 | — | — | 3,744 major competitor apps |
| topics | 71 | 100 | 50 | 72 31,124 competing apps Median installs: 2,194 Avg rating: 4.3 | — | — | 855 major competitor apps |
| following | 69 | 100 | 53 | 77 65,321 competing apps Median installs: 3,708 Avg rating: 4.0 | — | — | 3,349 major competitor apps |
| entry | 74 | 100 | 43 | 65 12,982 competing apps Median installs: 1,130 Avg rating: 3.9 | — | — | 353 major competitor apps |
| quick | 67 | 100 | 55 | 82 143,237 competing apps Median installs: 1,456 Avg rating: 4.0 | — | — | 6,861 major competitor apps |
| receive | 67 | 100 | 52 | 82 143,947 competing apps Median installs: 936 Avg rating: 4.0 | — | — | 4,686 major competitor apps |
| topic | 74 | 100 | 45 | 63 9,600 competing apps Median installs: 3,127 Avg rating: 4.2 | — | — | 290 major competitor apps |
| structure | 74 | 100 | 39 | 63 8,878 competing apps Median installs: 1,237 Avg rating: 4.1 | — | — | 258 major competitor apps |
App Description
The "onkowissen Biosimilars" app: innovative - interactive - educational
The app includes the following content:
• Biosimilar Radar: A dynamic representation of relevant data from biosimilar oncology and anti-inflammatory therapeutics as well as the biosimilars of pegfilgrastim.
• Latest News: Receive links to the latest news, such as regulatory approval information or new biosimilar publications of interest.
• Production, safety and approval of biosimilars: The most important points on the respective content are presented briefly and concisely.
• Everyday issues: topics such as switches, cost structure and differences between generics and biosimilars are discussed.
• Statements: Here you will find references to the current statements from specialist societies, commissions, authorities and industry.
• Glossary: The most important terms on the topic of biosimilars are explained in the glossary. The quick entry into the world of biosimilars.
The app also contains a news feed with links to new data and current topics related to biosimilars.
The app is for informational purposes only. It is intended only for specialist groups with an onkowissen.de login.